CEACAM5 and breast carcinoma: Carcinoembryonic antigen (CEA), as a broad-spectrum tumor biomarker, is a reliable indicator of lung cancer [21], gastric cancer [22], colorectal cancer [23], pancreatic cancer [24], and breast cancer [25].